Here you will find e-learning courses developed by PATH to support quality assurance (QA) programs for rapid diagnostic testing.
Quality Assurance for Surveillance Testing
Description: This course teaches the importance of robust quality assurance (QA) programs for surveillance testing and covers the components of an effective QA program.
This course will familiarize you with:
- Key terminology—lot testing, QA, quality control (QC), and quality assessment
- The rationale for QA for surveillance testing
- Benefits of QA implementation
- Components of an ideal QA program
Who should use this course:
- Diagnostic test technicians
- Surveillance testing program managers
- Researchers interested in using or developing QA programs for surveillance testing
- Anyone interested in expanding their knowledge of QA procedures in a surveillance setting
Duration: 30 minutes.
Quality Assurance for Onchocerciasis and Lymphatic Filariasis rapid tests
Description: PATH developed a comprehensive QA program for the SD BIOLINE Onchocerciasis and Lymphatic Filariasis rapid tests. This e-learning course provides step-by-step instructions on how to implement the QA program as part of surveillance for these diseases. Course modules can be completed independently or as part of a cascade training.
- Understand and describe the importance of a robust quality assurance program for rapid tests like the SD BIOLINE tests
- Learn how to perform SD BIOLINE onchocerciasis and lymphatic filariasis rapid tests and train others on the procedure
- Become familiar with the purpose and process for running the training, proficiency, quality control and quality assurance panels specifically designed for SD BIOLINE tests
- Learn to implement a robust quality assurance program for SD BIOLINE tests using resources (instructions, videos, data forms) developed by PATH
Who should use this course:
- Technicians and program managers using the SD BIOLINE Onchocerciasis and Lymphatic Filariasis IgG4 biplex test, SD BIOLINE Onchocerciasis IgG4 monoplex test, and/or SD BIOLINE Lymphatic Filariasis IgG4 monoplex test.
Duration: 95 minutes.
The course is divided into five parts:
- Module 1 | QA Program Introduction [15 minutes]
- Module 2 | The QA Panel [15 minutes]
- Module 3 | The Training Panel & Proficiency Panel [20 minutes]
- Module 4 | Daily QC [15 minutes]
- Module 5 | Preparing for Field Use and Best Practices for Implementing the QA Program [30 minutes]
Directions for accessing course.
- Go to G/3 Learning: Global Health, Global Impact, Global Learning center
- Create an account
- Accept the new user registration agreement
- Click continue
- Click the course catalogue, or search “Diagnostics”
- Courses are in the Diagnostics folder and open for enrollment
- Enroll in the course(s)
- Click “Show Sub-Modules” and “Launch” to begin.
Why is quality assurance important?
Quality assurance (QA) is essential for programs to monitor and improve the quality of diagnostic testing. QA is all of the systematic activities that demonstrate confidence that a product or service fulfills its requirements. (International Organization for Standardization) A QA program for diagnostics is designed to guarantee that the final diagnostic results reported by a laboratory or testing program are as accurate as possible. The process includes providing diagnostic test operators with quality training as well as verifying that tests perform as intended, giving program managers greater confidence in their test results. An important component of any QA program is quality control (QC) measures to indicate whether the test run was valid and produced acceptable results. Implementing diagnostic testing with rapid tests in parallel with a QA program reinforces the validity of the test results, builds capacity to use rapid tests for surveillance and research, and aligns with global guidance and best practices for the post-market surveillance of new diagnostic tools. A robust QA program benefits test developers, manufacturers, distributors, funders, policy makers, key stakeholders, and most importantly, the patients or communities where the diagnostics are used.